Advertisement

Neurological Sciences

, Volume 34, Issue 10, pp 1797–1803 | Cite as

Mini mental Parkinson test: standardization and normative data on an Italian sample

  • Alberto CostaEmail author
  • Eriola Bagoj
  • Marco Monaco
  • Silvia Zabberoni
  • Salvatore De Rosa
  • Ciro Mundi
  • Carlo Caltagirone
  • Giovanni Augusto Carlesimo
Original Article

Abstract

The mini mental Parkinson (MMP) is a test built to overcome the limits of the mini mental state examination (MMSE) in the short-time screening of cognitive disorders in individuals with Parkinson’s disease (PD). In fact, in this scale, items tapping executive functioning are included to better capture PD-related cognitive changes. Some data sustain the sensitivity and validity of the MMP in the short neuropsychological screening of these individuals. Here, we report normative data on the MMP we collected on a sample of 307 Italian healthy subjects ranging from 40 to 91 years. The results document a detrimental effect of age and an ameliorative effect of education on the MMP total performance score. We provide for correction grids for age and literacy that derive from results of the regression analyses. Moreover, we also computed equivalent scores in order to allow a direct and fast comparison between the performance on the MMP and on other psychometric measures that can be administered to the subjects.

Keywords

Mini mental Parkinson Parkinson’s disease Dementia Cognitive disorders Neuropsychological assessment 

Supplementary material

10072_2013_1342_MOESM1_ESM.pdf (194 kb)
Supplementary material 1 (PDF 194 kb)

References

  1. 1.
    Svenningsson P, Westman E, Ballard C, Aarsland D (2012) Cognitive impairment in patients with Parkinson’s disease: diagnosis, biomarkers, and treatment. Lancet Neurol 11(8):697–707PubMedCrossRefGoogle Scholar
  2. 2.
    Jacobs DM, Marder K, Cote LJ, Sano M, Stern Y, Mayeux R (1995) Neuropsychological characteristics of preclinical de- mentia in Parkinson’s disease. Neurology 45:1691PubMedCrossRefGoogle Scholar
  3. 3.
    Muslimovic D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65(8):1239–1245PubMedCrossRefGoogle Scholar
  4. 4.
    Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky K, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, Emre M (2010) Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75(12):1062–1069PubMedCrossRefGoogle Scholar
  5. 5.
    Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: movement disorder society task force guidelines. Mov Disord 27(3):349–356PubMedCrossRefGoogle Scholar
  6. 6.
    Kulisevsky J, Pagonabarraga J (2009) Cognitive impairment in Parkinson’s Disease: tools for diagnosis and assessment. Mov Disord 24(8):1103–1110PubMedCrossRefGoogle Scholar
  7. 7.
    Mahieux FMM, Boller F, Fermanian J, Guillard G (1995) Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson’s disease. Behav Neurol 8:15–22Google Scholar
  8. 8.
    Marinus J, Visser M, Verwey NA, Verhey FR, Middelkoop HA, Stiggelbout AM, van Hilten JJ (2003) Assessment of cognition in Parkinson’s disease. Neurology 61:1222–1228PubMedCrossRefGoogle Scholar
  9. 9.
    Kalbe E, Calabrese P, Kohn N, Hilker R, Riedel O, Wittchen HU, Dodel R, Otto J, Ebersbach G, Kessler J (2008) Screening for cognitive deficits in Parkinson’s disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument. Parkinsonism Relat Disord 14:93–101PubMedCrossRefGoogle Scholar
  10. 10.
    Pagonabarraga J, Kulisevsky J, Llebaria G, Garcia-Sanchez C, Pascua-Sedano B, Gironell A (2008) Parkinson’s disease-cognitive ratin-scale (PD-CRS): a new cognitive scale specific for Parkinson’s disease. Mov Disord 23:998–1005PubMedCrossRefGoogle Scholar
  11. 11.
    Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621–1626PubMedCrossRefGoogle Scholar
  12. 12.
    Appollonio I, Leone M, Isella V, Piamarta F, Consoli T, Villa ML, Forapani E, Russo A, Nichelli P (2005) The frontal assessment battery (FAB): normative values in an Italian population sample. Neurol Sci 26:108–116. doi: 10.1007/s10072-005-0443-4 PubMedCrossRefGoogle Scholar
  13. 13.
    Folstein MF, Folstein SE, McHugh PR (1975) ‘‘Mini-mental state’’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRefGoogle Scholar
  14. 14.
    Measso G, Cavarzeran F, Zappalà G, Lebowittz BD, Crook TH, Pirazzolo FJ, Amaducci LA, Massari D, Grigoletto F (1993) The Mini-Mental State Examination: normative study of an Italian random sample. Dev Neuropsychol 9:77–85CrossRefGoogle Scholar
  15. 15.
    Lima Cèsar F, Laura P, Fonseca R, Meireles LP, Castro SL, Garrett C (2008) The frontal assessment battery (FAB) in Parkinson’s disease and correlations with formal measures of executive functioning. J Neurol 255:1756–1761CrossRefGoogle Scholar
  16. 16.
    Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22(12):1689–1707PubMedCrossRefGoogle Scholar
  17. 17.
    Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D (2009) Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73:1738–1745PubMedCrossRefGoogle Scholar
  18. 18.
    Mamikonyan E, Moberg PJ, Siderowf A, Duda JE, Have TT, Hurtig HI, Stern MB, Weintrauba D (2009) Mild cognitive impairment is common in Parkinson’s disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord 15(3):226–231PubMedCrossRefGoogle Scholar
  19. 19.
    Emre M (2003) Dementia associated with Parkinson’s disease. Lancet Neurol 2(4):229–237PubMedCrossRefGoogle Scholar
  20. 20.
    Caslake CR, Summers F, McConachie D, Ferris C, Gordon JC, Harris CE, Caie L (2009) Mini-Mental Parkinson’s test as a cognitive screening tool in people with Parkinson’s disease. J Neurol Neurosurg Psychiatry 80:e3CrossRefGoogle Scholar
  21. 21.
    Parrao-Diaz T, Chana-Cuevas P, Juri-Claverias C, Kunstmann C, Tapia-Nunez J (2005) Evaluation of cognitive impairment in a population of patients with Parkinson’s disease by means of the mini mental Parkinson test [in Spanish]. Rev Neurol 40:339–344PubMedGoogle Scholar
  22. 22.
    Serrano-Dueñas M, Calero B, Serrano S, Serrano M, Coronel P (2010) Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson’s disease. Mov Disord 25:2555–2562PubMedCrossRefGoogle Scholar
  23. 23.
    American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, London (text revision)Google Scholar
  24. 24.
    Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(20):22–33PubMedGoogle Scholar
  25. 25.
    Spinnler H, Tognoni G (1987) Standardizzazione e Taratura Italiana di Test Neuropsicologici. Ital J Neurol Sci 6:25–27Google Scholar
  26. 26.
    Wilks SS (1941) Determination of sample sizes for setting tolerance limits. Ann Math Stat 12:91–96CrossRefGoogle Scholar
  27. 27.
    Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, Bottacchi E, Cannas A, Ceravolo G, Ceravolo R, Cicarelli G, Gaglio RM, Giglia RM, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Dotto PD, PRIAMO study group (2009) The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649PubMedCrossRefGoogle Scholar
  28. 28.
    Hughes TA, Ross HF, Mindham RH, Spokes EG (2004) Mortality in Parkinson’s disease and its association with dementia and depression. Acta Neurol Scand 110(2):118–123PubMedCrossRefGoogle Scholar
  29. 29.
    Owen AM (2004) Cognitive dysfunction in Parkinson’s disease: the role of frontostriatal circuitry. Neurosci 10:527–537Google Scholar
  30. 30.
    Cools R (2006) Dopaminergic modulation of cognitive function-implications for ldopa treatment in Parkinson’s disease. Neurosci Biobehav Rev 30:1–23PubMedCrossRefGoogle Scholar
  31. 31.
    Larner AJ (2012) Mini-Mental Parkinson (MMP) as a Dementia screening test: comparison with the Mini-Mental State Examination (MMSE). Curr Aging Sci 5(2):136–139PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2013

Authors and Affiliations

  • Alberto Costa
    • 1
    Email author
  • Eriola Bagoj
    • 2
  • Marco Monaco
    • 1
  • Silvia Zabberoni
    • 1
  • Salvatore De Rosa
    • 2
  • Ciro Mundi
    • 2
  • Carlo Caltagirone
    • 3
  • Giovanni Augusto Carlesimo
    • 3
  1. 1.IRCCS Fondazione Santa LuciaRomeItaly
  2. 2.Azienda Ospedaliero-Univeristaria O.O.R.R, Ospedali Riuniti FoggiaFoggiaItaly
  3. 3.IRCCS Fondazione Santa Lucia and Università di Roma “Tor Vergata”RomeItaly

Personalised recommendations